NCT04996394View on ClinicalTrials.gov

"Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS"

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

December 12, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
ARDSNeuromuscular Blockade
Trial Locations (1)

20900

ASST Monza, Monza

All Listed Sponsors
lead

University of Milano Bicocca

OTHER

NCT04996394 - "Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS" | Biotech Hunter | Biotech Hunter